Clinical Trial Update: Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating a triple chemotherapy regimen (induction, concurrent, and adjuvant) for high-risk nasopharyngeal carcinoma; the current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN